Ufp Technologies (UFPT) Change in Receivables (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Change in Receivables came in at $14.8 million in Q2 2026, up 245.7% on a YoY basis from $4.3 million in Q2 2025, and down 5.72% quarter-over-quarter from $15.7 million in Q1 2026.
Analysis
Ufp Technologies (UFPT) Change in Receivables (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported Change in Receivables for 17 consecutive years, with $14.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Receivables rose 245.7% year-over-year to $14.8 million; the trailing twelve-month figure through Jun 2026 stood at $26.5 million (up 1412.58% YoY), and the FY2025 full-year result was -$5.3 million, down 338.54% from the prior year.
- Change in Receivables slipped to $14.8 million in Q2 2026 per UFPT's latest filing, from $15.7 million in the prior quarter.
- Across five years, Change in Receivables topped out at $15.7 million in Q1 2026 and bottomed at -$10.2 million in Q2 2025.
- Historically, Change in Receivables has averaged $2.8 million across 5 years, with a median of $3.4 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables soared 888.04% in 2022, then plunged 816.04% in 2025.
- Over 5 years, Change in Receivables stood at -$3.0 million in 2022, then surged by 211.96% to $3.3 million in 2023, then sank by 223.31% to -$4.1 million in 2024, then surged by 46.18% to -$2.2 million in 2025, then jumped by 769.76% to $14.8 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $14.8 million, $15.7 million, and -$2.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | 14.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.82 Mn |
| Mar 31, 2026 | 15.71 Mn |
| Dec 31, 2025 | -2.21 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | -10.17 Mn |
| Mar 31, 2025 | 8.90 Mn |
| Dec 31, 2024 | -4.11 Mn |
| Sep 30, 2024 | 7.12 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | -3.12 Mn |
| Dec 31, 2023 | 3.33 Mn |
| Sep 30, 2023 | -3.02 Mn |
| Jun 30, 2023 | 3.94 Mn |
| Mar 31, 2023 | 4.86 Mn |
| Dec 31, 2022 | -2.98 Mn |
| Sep 30, 2022 | 3.48 Mn |
| Jun 30, 2022 | 11.90 Mn |
| Mar 31, 2022 | 4.47 Mn |
| Dec 31, 2021 | 1.73 Mn |
| Sep 30, 2021 | 1.23 Mn |